Work Fatigue Among Air Personnel: Protocol for Fatigue Intervention Program (FIP) and Quasi Experimental Study

• DOI: 10.47836/mjmhs.20.2.46
• Publication Date: 2024-12-12T13:11:31Z
• Authors: Kamesh Rajendran; Victor C W Hoe; Mahmoud Danaee; Mohd Asghar Khan ...; Mohammed Haizar H...; Omar Dawami; Muhammad Taha Hamdan; Mohd Khairol Fadl...; Faizul Hussien Da...; Zulazri Ibrahim; Paranjothi Manogh...; Tzai Meng Onn; Ravin Vijayan; Hari Prasad Rao R...; Saifulsyahira Jaaman; Nurul Hani Shamsu...; Umashankar Subram...; Priya Nandimath; Mohd Shahril Abu ...; Balwant Singh Bains; Mina Pushpanathan; Siti Nuraini Hassan; Rosli Kolob

Introduction: Work fatigue is common in air and ground crew since they have prolonged working hours. excessive tiredness decreased function during or after work. Fatigue can also affect sleep quality. Despite work causing disproportionately significant psychosocial dangers, limited studies developed an intervention program. Thus, this study will develop a Intervention Program (FIP) evaluate its effectiveness reducing fatigue. Methods: The FIP was literature review expert’s evaluation. This quasi-experimental to the of FIP. One east Malaysia base be arm one west control arm. Each comprise 61 participants for total N=122. (primary outcome) quality (secondary evaluated using Multidimensional Inventory (MFI) Pittsburgh Sleep Quality Index (PSQI) questionnaires respectively. Baseline, post-intervention, post one-month, three-month assessments done both arms. Data described by percentages, frequencies, mean. Time group interaction effects examined General Estimating Equation. Discussion: Five experts gave Content Validity 0.90 1.00 relevancy, clarity, adequacy, agreeability evaluation Enrolment take month data collection three months. expected reduce domains MFI such as reduced motivation, activity, general, physical mental improve PSQI domains; duration sleep, days dysfunction due sleepiness, disturbance, efficiency, latency, Trial Registration: has been registered Thai Clinical Trials Registry with approval number TCTR20221004004.